Sunnyvale, California - March 20, 2022

​​

MissionDao Investment Corp today announced that it has completed a follow-on investment in mProbe Inc., building on MissionDao’s prior investment and continued support of the company’s technology and growth strategy.

​

mProbe is a U.S.-based life sciences company focused on advanced molecular and protein analysis technologies that enable high-sensitivity and scalable biological measurement. Since MissionDao’s initial investment in 2017, mProbe has continued to advance its platform capabilities and strengthen its position within research and biotechnology markets.

​

“This follow-on investment reflects our continued conviction in mProbe’s technology, execution, and long-term potential,” said MissionDao management. “We are pleased to deepen our partnership and support the company as it enters its next phase of development.”

​

The investment aligns with MissionDao’s broader strategy of supporting innovative, science-driven companies through multiple stages of growth and value creation.

​​

MissionDao Investment Corp is a U.S.-based investment and operating company focused on life sciences, advanced technologies, and intellectual-property-driven assets.

​​​

For inquiries related to this announcement or MissionDao’s portfolio, please contact:

​MissionDao Investment Corp
Email: office@missiondaocorp.com